{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T02:57:03Z","timestamp":1789095423571,"version":"build-2803163510"},"reference-count":155,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmedsci.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.amjms.2025.10.023","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:08:43Z","timestamp":1761782923000},"page":"158-169","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Streptococcal infections: Emerging trends, clinical spectrum and global prevention effort"],"prefix":"10.1016","volume":"371","author":[{"given":"Cierra A.","family":"Bennett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A","family":"Almahal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarina","family":"Popovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Babiker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Bronze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.amjms.2025.10.023_bib0001","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1099\/00207713-34-1-31","article-title":"Transfer of Streptococcus faecalis and Streptococcus faecium to the genus enterococcus nom. rev. as Enterococcus faecalis comb. nov. and Enterococcus faecium comb","volume":"34","author":"Schleifer","year":"1984","journal-title":"Int J Syst Bacteriol"},{"issue":"1","key":"10.1016\/j.amjms.2025.10.023_bib0002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clinmicnews.2016.12.001","article-title":"Streptococcus bovis: 100 years of an intriguing pathogen","volume":"39","author":"Corredoira","year":"2017","journal-title":"Clin Microbiol Newsl"},{"issue":"5","key":"10.1016\/j.amjms.2025.10.023_bib0003","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0126507","article-title":"Potential transmission pathways of Streptococcus gallolyticus subsp. gallolyticus","volume":"10","author":"Dumke","year":"2015","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.amjms.2025.10.023_bib0004","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/phar.1922","article-title":"Role of combination antimicrobial therapy for vancomycin-resistant Enterococcus faecium","volume":"37","author":"Yim","year":"2017","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.amjms.2025.10.023_bib0005","series-title":"Enterococcus Infections","author":"Said","year":"2022"},{"issue":"1","key":"10.1016\/j.amjms.2025.10.023_bib0007","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1006\/cyto.1999.0521","article-title":"Production of cytokines by monocytes, epithelial and endothelial cells activated by Streptococcus bovis","volume":"12","author":"Ellmerich","year":"2000","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/j.amjms.2025.10.023_bib0008","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2407-9-403","article-title":"Investigation into the controversial association of Streptococcus gallolyticus with colorectal cancer and adenoma","volume":"9","author":"Abdulamir","year":"2009","journal-title":"BMC Cancer"},{"issue":"8","key":"10.1016\/j.amjms.2025.10.023_bib0009","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1093\/carcin\/bgh091","article-title":"Carcinogenic properties of proteins with pro-inflammatory activity from Streptococcus infantarius (formerly S.bovis)","volume":"25","author":"Biarc","year":"2004","journal-title":"Carcinogenesis"},{"issue":"7","key":"10.1016\/j.amjms.2025.10.023_bib0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006440","article-title":"Streptococcus gallolyticus subsp. gallolyticus promotes colorectal tumor development","volume":"13","author":"Kumar","year":"2017","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.amjms.2025.10.023_bib0011","doi-asserted-by":"crossref","DOI":"10.12659\/MSM.921886","article-title":"Streptococcus bovis contributes to the development of colorectal cancer via recruiting CD11b+TLR-4+ cells","volume":"26","author":"Deng","year":"2020","journal-title":"Med Sci Monit"},{"issue":"1","key":"10.1016\/j.amjms.2025.10.023_bib0012","article-title":"A type VII secretion system of Streptococcus gallolyticus subsp. gallolyticus contributes to gut colonization and the development of colon tumors","volume":"17","author":"Culver Taylor","year":"2021","journal-title":"PLoS Pathog"},{"issue":"1","key":"10.1016\/j.amjms.2025.10.023_bib0013","doi-asserted-by":"crossref","first-page":"6291","DOI":"10.1038\/s41598-023-33178-z","article-title":"A pathogenicity locus of Streptococcus gallolyticus subspecies gallolyticus","volume":"13","author":"Culver Taylor","year":"2023","journal-title":"Sci Rep"},{"issue":"614","key":"10.1016\/j.amjms.2025.10.023_bib0014","article-title":"Significance of Streptococcus gallolyticus subsp. gallolyticus association with colorectal cancer","volume":"9","author":"Pasquereau-Kotula","year":"2018","journal-title":"Front Microbiol"},{"issue":"01","key":"10.1016\/j.amjms.2025.10.023_bib0006","doi-asserted-by":"crossref","first-page":"e117","DOI":"10.1055\/a-1762-0096","article-title":"Early-Onset fulminant sepsis in a preterm neonate due to Streptococcus gallolyticus: a Case Report and Literature Review","volume":"12","author":"Williams","year":"2022","journal-title":"Am J Perinatol Reports"},{"issue":"4","key":"10.1016\/j.amjms.2025.10.023_bib0015","doi-asserted-by":"crossref","DOI":"10.1128\/jcm.01712-22","article-title":"Comparative evaluation of current biochemical-, sequencing and proteomic-based identification methods for the Streptococcus bovis group","volume":"61","author":"Putnam","year":"2023","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.amjms.2025.10.023_bib0016","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2018.01294","article-title":"Whole-cell MALDI-TOF MS versus 16S rRNA gene analysis for identification and dereplication of recurrent bacterial isolates","volume":"9","author":"Strejcek","year":"2018","journal-title":"Front Microbiol"},{"issue":"2","key":"10.1016\/j.amjms.2025.10.023_bib0017","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3390\/diagnostics12020328","article-title":"Rapid and reproducible MALDI-TOF-based method for the detection of vancomycin-resistant Enterococcus faecium using classifying algorithms","volume":"12","author":"Candela","year":"2022","journal-title":"Diagnostics"},{"key":"10.1016\/j.amjms.2025.10.023_bib0018","article-title":"Efficiently predicting vancomycin resistance of Enterococcus Faecium from MALDI-TOF MS Spectra using a deep learning-based approach","volume":"13","author":"Wang","year":"2022","journal-title":"Front Microbiol"},{"issue":"4","key":"10.1016\/j.amjms.2025.10.023_bib0019","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1021\/acsinfecdis.3c00737","article-title":"Lusutrombopag as a repurposing drug in combination with aminoglycosides against vancomycin-resistant enterococcus","volume":"10","author":"She","year":"2024","journal-title":"ACS Infect Dis"},{"issue":"2","key":"10.1016\/j.amjms.2025.10.023_bib0020","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41579-018-0107-z","article-title":"Biofilm-associated infection by enterococci","volume":"17","author":"Ch\u2019ng","year":"2018","journal-title":"Nat Rev Microbiol"},{"issue":"6","key":"10.1016\/j.amjms.2025.10.023_bib0021","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00085-19","article-title":"Bacteriophage resistance alters antibiotic-mediated intestinal expansion of enterococci","volume":"87","author":"Chatterjee","year":"2019","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.amjms.2025.10.023_bib0022","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01653-16","article-title":"Antibody-based therapy for enterococcal catheter-associated urinary tract infections","volume":"7","author":"Flores-Mireles","year":"2016","journal-title":"mBio"},{"issue":"4","key":"10.1016\/j.amjms.2025.10.023_bib0023","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1128\/IAI.01403-13","article-title":"Targeting pili in enterococcal pathogenesis","volume":"82","author":"Pinkston","year":"2014","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.amjms.2025.10.023_bib0024","doi-asserted-by":"crossref","first-page":"fuae009","DOI":"10.1093\/femsre\/fuae009","article-title":"An opportunistic pathogen under stress: how Group B Streptococcus responds to cytotoxic reactive species and conditions of metal ion imbalance to survive","volume":"48","author":"Goh","year":"2024","journal-title":"FEMS Microbiol Rev"},{"issue":"1","key":"10.1016\/j.amjms.2025.10.023_bib0025","doi-asserted-by":"crossref","DOI":"10.1128\/cmr.00154-22","article-title":"Group B streptococcal infections in pregnancy and early life","volume":"38","author":"Manuel","year":"2025","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"10.1016\/j.amjms.2025.10.023_bib0026","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1097\/GRF.0000000000000883","article-title":"Novel Insights on Group B Streptococcus in Pregnancy","volume":"67","author":"Litman","year":"2024","journal-title":"Clin Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.amjms.2025.10.023_bib0027","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.vaccine.2022.11.024","article-title":"Simultaneous carriage of multiple serotypes of Group B Streptococcus: systematic review and meta-analysis","volume":"41","author":"Barro","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.amjms.2025.10.023_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102748","article-title":"Intrapartum antibiotic prophylaxis to prevent Group B streptococcal infections in newborn infants: a systematic review and meta-analysis comparing various strategies","volume":"74","author":"Panneflek","year":"2024","journal-title":"EClinicalMedicine"},{"issue":"2","key":"10.1016\/j.amjms.2025.10.023_bib0029","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3390\/pathogens12020229","article-title":"Strategies to Prevent Early and Late-Onset Group B Streptococcal Infection via Interventions in Pregnancy","volume":"12","author":"Delara","year":"2023","journal-title":"Pathogens"},{"issue":"9","key":"10.1016\/j.amjms.2025.10.023_bib0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0258030","article-title":"Burden of invasive group B Streptococcus disease in non-pregnant adults: a systematic review and meta-analysis. Melo-Cristino J","volume":"16","author":"Navarro-Torn\u00e9","year":"2021","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.amjms.2025.10.023_bib0031","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.3390\/microorganisms10122483","article-title":"Group B streptococcus: virulence factors and pathogenic mechanism","volume":"10","author":"Liu","year":"2022","journal-title":"Microorganisms"},{"issue":"9","key":"10.1016\/j.amjms.2025.10.023_bib0032","doi-asserted-by":"crossref","first-page":"671","DOI":"10.2217\/fmb-2020-0189","article-title":"Pathogenic Mechanism, Detection Methods and Clinical Significance of Group B Streptococcus","volume":"16","author":"Yuan","year":"2021","journal-title":"Future Microbiol"},{"issue":"11","key":"10.1016\/j.amjms.2025.10.023_bib0033","article-title":"Molecular epidemiology of Streptococcus agalactiae in non-pregnant populations: a systematic review","volume":"9","author":"Founou","year":"2023","journal-title":"Microb Genom"},{"issue":"suppl_2","key":"10.1016\/j.amjms.2025.10.023_bib0034","doi-asserted-by":"crossref","first-page":"S160","DOI":"10.1093\/cid\/cix656","article-title":"Infant Group B Streptococcal Disease Incidence and Serotypes Worldwide: systematic Review and Meta-analyses","volume":"65","author":"Madrid","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"suppl_2","key":"10.1016\/j.amjms.2025.10.023_bib0035","doi-asserted-by":"crossref","first-page":"S100","DOI":"10.1093\/cid\/cix658","article-title":"Maternal Colonization With Group B Streptococcus and Serotype Distribution Worldwide: systematic Review and Meta-analyses","volume":"65","author":"Russell","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.amjms.2025.10.023_bib0036","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1186\/s12879-024-10337-9","article-title":"Serotype distribution and clinical characteristics of Group B Streptococcus Bacteremia in nonpregnant adults: a 15-Year Multicenter Study in Korea","volume":"24","author":"Kim","year":"2024","journal-title":"BMC Infect Dis"},{"issue":"9","key":"10.1016\/j.amjms.2025.10.023_bib0037","doi-asserted-by":"crossref","first-page":"807","DOI":"10.3390\/pathogens13090807","article-title":"Group B Streptococcus Infections in Non-Pregnant Adults, Italy, 2015\u20132019","volume":"13","author":"Imperi","year":"2024","journal-title":"Pathogens"},{"issue":"1","key":"10.1016\/j.amjms.2025.10.023_bib0038","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/s41598-020-79354-3","article-title":"Trends in molecular characteristics and antimicrobial resistance of group B streptococci: a multicenter study in Serbia, 2015\u20132020","volume":"11","author":"Kekic","year":"2021","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.amjms.2025.10.023_bib0067","doi-asserted-by":"crossref","first-page":"249.e1","DOI":"10.1016\/j.ajog.2011.06.024","article-title":"Efficacy of polymeric encapsulated C5a peptidase\u2013based group B streptococcus vaccines in a murine model","volume":"205","author":"Santillan","year":"2011","journal-title":"Am J Obstet Gynecol"},{"issue":"suppl_2","key":"10.1016\/j.amjms.2025.10.023_bib0068","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1093\/cid\/cix660","article-title":"Maternal Disease With Group B Streptococcus and Serotype Distribution Worldwide: systematic Review and Meta-analyses","volume":"65","author":"Hall","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.amjms.2025.10.023_bib0069","doi-asserted-by":"crossref","first-page":"e306","DOI":"10.1097\/INF.0000000000002050","article-title":"Bacterial Load and Molecular Markers Associated With Early-onset Group B Streptococcus: a Systematic Review and Meta-analysis","volume":"37","author":"Seedat","year":"2018","journal-title":"Pediat Infect Dis J"},{"issue":"4","key":"10.1016\/j.amjms.2025.10.023_bib0070","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1001\/jamainternmed.2018.7269","article-title":"Epidemiology of Invasive Group B Streptococcal Infections Among Nonpregnant Adults in the United States, 2008-2016","volume":"179","author":"Francois Watkins","year":"2019","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.amjms.2025.10.023_bib0039","series-title":"Microbiol Spectr","first-page":"17","article-title":"Group B Streptococcus (Streptococcus agalactiae)","volume":"7","author":"Raabe","year":"2019"},{"issue":"9","key":"10.1016\/j.amjms.2025.10.023_bib0040","doi-asserted-by":"crossref","first-page":"e241","DOI":"10.1097\/INF.0000000000001931","article-title":"Group B Streptococcal Cellulitis and Necrotizing Fasciitis in Infants: a Systematic Review","volume":"37","author":"Wojtera","year":"2018","journal-title":"Pediat Infect Dis J"},{"issue":"3","key":"10.1016\/j.amjms.2025.10.023_bib0041","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jinf.2019.12.002","article-title":"Community-acquired group B streptococcal meningitis in adults","volume":"80","author":"Van Kassel","year":"2020","journal-title":"J Infect"},{"issue":"12","key":"10.1016\/j.amjms.2025.10.023_bib0042","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.3390\/microorganisms10122398","article-title":"Updates on Group B Streptococcus Infection in the Field of Obstetrics and Gynecology","volume":"10","author":"Choi","year":"2022","journal-title":"Microorganisms"},{"issue":"3","key":"10.1016\/j.amjms.2025.10.023_bib0043","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/GRF.0000000000000884","article-title":"Group B Streptococcus and Intraamniotic Inflammation and Infection","volume":"67","author":"Afsari","year":"2024","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.amjms.2025.10.023_bib0044","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ejogrb.2024.11.035","article-title":"Accuracy of real-time polymerase chain reaction test for Group B Streptococcus detection in pregnant women: a systematic review and meta-analysis","volume":"304","author":"Peng","year":"2025","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"suppl_2","key":"10.1016\/j.amjms.2025.10.023_bib0045","doi-asserted-by":"crossref","first-page":"S143","DOI":"10.1093\/cid\/cix654","article-title":"Intrapartum Antibiotic Chemoprophylaxis Policies for the Prevention of Group B Streptococcal Disease Worldwide: systematic Review","volume":"65","author":"Le Doare","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.amjms.2025.10.023_bib0046","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/MOP.0000000000001223","article-title":"20 million pregnant women with group B streptococcus carriage: consequences, challenges, and opportunities for prevention","volume":"35","author":"Paul","year":"2023","journal-title":"Curr Opin Pediatr"},{"issue":"suppl_2","key":"10.1016\/j.amjms.2025.10.023_bib0047","doi-asserted-by":"crossref","first-page":"S152","DOI":"10.1093\/cid\/cix655","article-title":"Risk of Early-Onset Neonatal Group B Streptococcal Disease With Maternal Colonization Worldwide: systematic Review and Meta-analyses","volume":"65","author":"Russell","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.amjms.2025.10.023_bib0048","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1001\/jamapediatrics.2018.4826","article-title":"Epidemiology of Invasive Early-Onset and Late-Onset Group B Streptococcal Disease in the United States, 2006 to 2015: multistate Laboratory and Population-Based Surveillance","volume":"173","author":"Nanduri","year":"2019","journal-title":"JAMA Pediatr"},{"issue":"7","key":"10.1016\/j.amjms.2025.10.023_bib0049","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.3390\/medicina59071279","article-title":"Clinical Characteristics and Treatment Strategies for Group B Streptococcus (GBS) Infection in Pediatrics: a Systematic Review","volume":"59","author":"Alotaibi","year":"2023","journal-title":"Medicina (B Aires)"},{"key":"10.1016\/j.amjms.2025.10.023_bib0050","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jgar.2016.08.010","article-title":"Alarming regional differences in prevalence and antimicrobial susceptibility of group B streptococci in pregnant women: a systematic review and meta-analysis","volume":"7","author":"Huang","year":"2016","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.amjms.2025.10.023_bib0051","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3389\/fmicb.2018.00437","article-title":"Group B Streptococcal Colonization, Molecular Characteristics, and Epidemiology","volume":"9","author":"Shabayek","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.amjms.2025.10.023_bib0052","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1430901","article-title":"Vaccines for Streptococcus agalactiae: current status and future perspectives","volume":"15","author":"Pena","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.amjms.2025.10.023_bib0053","article-title":"Current research update on group B streptococcal infection related to obstetrics and gynecology","volume":"15","author":"Liu","year":"2024","journal-title":"Front Pharmacol"},{"issue":"32","key":"10.1016\/j.amjms.2025.10.023_bib0054","doi-asserted-by":"crossref","first-page":"4489","DOI":"10.1016\/j.vaccine.2021.06.046","article-title":"Safety and immunogenicity of a prototype recombinant alpha-like protein subunit vaccine (GBS-NN) against Group B Streptococcus in a randomised placebo-controlled double-blind phase 1 trial in healthy adult women","volume":"39","author":"Fischer","year":"2021","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.amjms.2025.10.023_bib0055","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.vaccine.2023.11.056","article-title":"The immunogenicity and safety of Group B Streptococcal maternal vaccines: a systematic review","volume":"42","author":"Bjerkhaug","year":"2024","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.amjms.2025.10.023_bib0056","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1056\/NEJMoa2116045","article-title":"Potential for Maternally Administered Vaccine for Infant Group B Streptococcus","volume":"389","author":"Madhi","year":"2023","journal-title":"N Engl J Med"},{"issue":"43","key":"10.1016\/j.amjms.2025.10.023_bib0057","doi-asserted-by":"crossref","first-page":"6682","DOI":"10.1016\/j.vaccine.2020.08.052","article-title":"Systematic review of Group B Streptococcal capsular types, sequence types and surface proteins as potential vaccine candidates","volume":"38","author":"Bianchi-Jassir","year":"2020","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.amjms.2025.10.023_bib0058","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-79503-y","article-title":"Bioinformatics analysis to design a multi-epitope mRNA vaccine against S. agalactiae exploiting pathogenic proteins","volume":"14","author":"Barazesh","year":"2024","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.amjms.2025.10.023_bib0059","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1093\/cid\/ciac206","article-title":"Clinical Risk Factors Associated With Late-Onset Invasive Group B Streptococcal Disease: systematic Review and Meta-Analyses","volume":"75","author":"Karampatsas","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjms.2025.10.023_bib0060","doi-asserted-by":"crossref","DOI":"10.1177\/11795565241281337","article-title":"Neonatal Sepsis: etiology, Pathophysiology, Diagnostic Advances and Management Strategies","volume":"18","author":"Raturi","year":"2024","journal-title":"Clin Med Insights Pediatr"},{"issue":"3","key":"10.1016\/j.amjms.2025.10.023_bib0061","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3390\/antibiotics12030489","article-title":"Group B Streptococcus Early-Onset Disease: new Preventive and Diagnostic Tools to Decrease the Burden of Antibiotic Use","volume":"12","author":"Nusman","year":"2023","journal-title":"Antibiotics"},{"issue":"1","key":"10.1016\/j.amjms.2025.10.023_bib0062","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s12866-023-02877-y","article-title":"Antibiotic resistance, biofilm formation, and virulence genes of Streptococcus agalactiae serotypes of Indian origin","volume":"23","author":"Verma","year":"2023","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.amjms.2025.10.023_bib0063","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jgar.2023.02.004","article-title":"Prevalence of Group B Streptococcus maternal colonization, serotype distribution, and antimicrobial resistance in Sub-Saharan Africa: a systematic review and meta-analysis","volume":"32","author":"Wadilo","year":"2023","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.amjms.2025.10.023_bib0064","doi-asserted-by":"crossref","DOI":"10.1016\/j.midw.2021.103208","article-title":"Probiotic interventions to reduce antepartum Group B streptococcus colonization: a systematic review and meta-analysis","volume":"105","author":"Hanson","year":"2022","journal-title":"Midwifery"},{"issue":"21","key":"10.1016\/j.amjms.2025.10.023_bib0065","doi-asserted-by":"crossref","first-page":"4520","DOI":"10.3390\/nu14214520","article-title":"Supplementation of Probiotics in Pregnant Women Targeting Group B Streptococcus Colonization: a Systematic Review and Meta-Analysis","volume":"14","author":"Menichini","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.amjms.2025.10.023_bib0066","article-title":"Transmission of Group B Streptococcus in late-onset neonatal disease: a narrative review of current evidence","volume":"9","author":"Miselli","year":"2022","journal-title":"TherapeutAdv Infect"},{"issue":"11","key":"10.1016\/j.amjms.2025.10.023_bib0071","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S1473-3099(05)70267-X","article-title":"The global burden of group A streptococcal diseases","volume":"5","author":"Carapetis","year":"2005","journal-title":"Lancet Infect Dis."},{"key":"10.1016\/j.amjms.2025.10.023_bib0072","author":"Cunningham"},{"issue":"2","key":"10.1016\/j.amjms.2025.10.023_bib0073","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1128\/CMR.00101-13","article-title":"Disease manifestations and pathogenic mechanisms of group A Streptococcus","volume":"27","author":"Walker","year":"2014","journal-title":"Clin Microbiol Rev"},{"issue":"8","key":"10.1016\/j.amjms.2025.10.023_bib0074","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0136789","article-title":"The global epidemiology of impetigo: a systematic review of the population prevalence of impetigo and pyoderma","volume":"10","author":"Bowen","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.amjms.2025.10.023_bib0075","article-title":"The global burden of sore throat and group A Streptococcus pharyngitis: a systematic review and meta-analysis","volume":"48","author":"Miller","year":"2022","journal-title":"eClinical Medicine"},{"issue":"2","key":"10.1016\/j.amjms.2025.10.023_bib0076","doi-asserted-by":"crossref","first-page":"e181","DOI":"10.1016\/S2666-5247(23)00318-X","article-title":"Global Streptococcus pyogenes strain diversity, disease associations, and implications for vaccine development: a systematic review","volume":"5","author":"Smeesters","year":"2024","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.amjms.2025.10.023_bib0080","article-title":"Invasive Group A Streptococcal Infections in 10 US States","author":"Gregory","year":"2025","journal-title":"JAMA"},{"issue":"20","key":"10.1016\/j.amjms.2025.10.023_bib0156","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1161\/CIR.0000000000000205","article-title":"Revision of the Jones Criteria for the diagnosis of acute rheumatic fever in the era of Doppler echocardiography: a scientific statement from the American Heart Association","volume":"131","author":"Gewitz","year":"2015","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.amjms.2025.10.023_bib0077","doi-asserted-by":"crossref","first-page":"ofad188","DOI":"10.1093\/ofid\/ofad188","article-title":"Unexpected Increase in Invasive Group A Streptococcal Infections in Children After Respiratory Viruses Outbreak in France: a 15-Year Time-Series Analysis","volume":"10","author":"Lassoued","year":"2023","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"10.1016\/j.amjms.2025.10.023_bib0078","doi-asserted-by":"crossref","first-page":"3916","DOI":"10.1038\/s41467-024-47929-7","article-title":"Rapid expansion and international spread of M1UK in the post-pandemic UK upsurge of Streptococcus pyogenes","volume":"15","author":"Vieira","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.amjms.2025.10.023_bib0081","first-page":"41","article-title":"Increase in invasive group A streptococcal disease among Australian children coinciding with northern hemisphere surges","author":"Abo","year":"2023","journal-title":"The Lancet Regional Health \u2013 Western Pacific"},{"issue":"7","key":"10.1016\/j.amjms.2025.10.023_bib0082","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S2666-5247(24)00071-5","article-title":"Epidemiology of group A streptococcal infection: are we ready for a new scenario?","volume":"5","author":"Massese","year":"2024","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.amjms.2025.10.023_bib0083","doi-asserted-by":"crossref","first-page":"ciae493","DOI":"10.1093\/cid\/ciae493","article-title":"Cycles of Susceptibility: immunity Debt Explains Altered Infectious Disease Dynamics Post-Pandemic","author":"Munro","year":"2024","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjms.2025.10.023_bib0084","doi-asserted-by":"crossref","unstructured":"Lancefield R.C. The Antigenic Complex of Streptococcus Hemolyticus. I. Demonstration Of A Type-Specific Substance in Extracts of Streptococcus Hemolyticus.; 1928. doi:10.1084\/jem.47.1.91.","DOI":"10.1084\/jem.47.1.91"},{"issue":"8","key":"10.1016\/j.amjms.2025.10.023_bib0085","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.3201\/eid2508.181758","article-title":"Emergent Invasive Group A Streptococcus dysgalactiae subsp. equisimilis, United States, 2015\u20132018","volume":"25","author":"Chochua","year":"2019","journal-title":"Emerg Infect Dis J"},{"issue":"4","key":"10.1016\/j.amjms.2025.10.023_bib0086","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.idc.2022.07.007","article-title":"ICU Management of Invasive \u03b2-Hemolytic Streptococcal Infections","volume":"36","author":"Babiker","year":"2022","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.amjms.2025.10.023_bib0087","article-title":"Global genomic epidemiology of Streptococcus pyogenes","volume":"86","author":"Jespersen","year":"2020","journal-title":"Infect, Genet Evolut"},{"key":"10.1016\/j.amjms.2025.10.023_bib0088","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.meegid.2014.10.011","article-title":"Molecular epidemiology and genomics of group A Streptococcus","volume":"33","author":"Bessen","year":"2015","journal-title":"Infect, Genet Evol"},{"key":"10.1016\/j.amjms.2025.10.023_bib0089","author":"Beall"},{"key":"10.1016\/j.amjms.2025.10.023_bib0090","first-page":"99","article-title":"A global snapshot on the prevalent macrolide-resistant emm types of Group A Streptococcus worldwide, their phenotypes and their resistance marker genotypes during the last two decades: a systematic review","author":"Rafei","year":"2022","journal-title":"Infect, Genet Evol"},{"issue":"7","key":"10.1016\/j.amjms.2025.10.023_bib0091","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/s41579-023-00865-7","article-title":"Pathogenesis, epidemiology and control of Group A Streptococcus infection","volume":"21","author":"Brouwer","year":"2023","journal-title":"Nat Rev Microbiol"},{"issue":"5","key":"10.1016\/j.amjms.2025.10.023_bib0092","doi-asserted-by":"crossref","first-page":"402","DOI":"10.4161\/viru.2.5.16342","article-title":"The M protein of group A streptococcus is a key virulence factor and a clinically relevant strain identification marker","volume":"2","author":"Metzgar","year":"2011","journal-title":"Virulence"},{"issue":"9","key":"10.1016\/j.amjms.2025.10.023_bib0093","article-title":"Streptococcus pyogenes: pathogenesis and the Current Status of Vaccines","volume":"11","author":"Wang","year":"2023","journal-title":"Vaccines (Basel)"},{"issue":"10","key":"10.1016\/j.amjms.2025.10.023_bib0094","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1111\/imcb.12499","article-title":"Streptolysins are the primary inflammasome activators in macrophages during Streptococcus pyogenes infection","volume":"99","author":"Richter","year":"2021","journal-title":"Immunol Cell Biol"},{"issue":"10","key":"10.1016\/j.amjms.2025.10.023_bib0095","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1038\/s41564-017-0005-6","article-title":"Group A streptococcal M protein activates the NLRP3 inflammasome","volume":"2","author":"Valderrama","year":"2017","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.amjms.2025.10.023_bib0096","doi-asserted-by":"crossref","unstructured":"Dale J.B., Beachey E.H. Brief Definitive Report Sequence of Myosin-Crossreactive Epitopes of Streptococcal M Protein.; 1986. doi:10.1084\/jem.47.1.91.","DOI":"10.1084\/jem.164.5.1785"},{"key":"10.1016\/j.amjms.2025.10.023_bib0097","doi-asserted-by":"crossref","unstructured":"Norgren\u2019 M., Eriksson A. Streptococcal Superantigens and Their Roles in The Pathogenesis of Severe Infections. Vol 16.; 1997. doi:https:\/\/doi.org\/10.3109\/15569549709064091.","DOI":"10.3109\/15569549709064091"},{"issue":"22","key":"10.1016\/j.amjms.2025.10.023_bib0098","doi-asserted-by":"crossref","first-page":"15854","DOI":"10.1074\/jbc.M113.469106","article-title":"Cysteine proteinase from Streptococcus pyogenes enables evasion of innate immunity via degradation of complement factors","volume":"288","author":"Honda-Ogawa","year":"2013","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.amjms.2025.10.023_bib0099","article-title":"The cysteine proteinase SpeB from Streptococcus pyogenes \u2013 a potent modifier of immunologically important host and bacterial proteins","author":"Nelson","year":"2011","journal-title":"Biol Chem"},{"key":"10.1016\/j.amjms.2025.10.023_bib0100","doi-asserted-by":"crossref","unstructured":"Shet A., Kaplan E.L., Johnson D.R., et al. Immune Response to Group A Streptococcal C5a Peptidase in Children: implications for Vaccine Development.; 2003.","DOI":"10.1086\/377700"},{"key":"10.1016\/j.amjms.2025.10.023_bib0101","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.csbj.2020.03.004","article-title":"Structure, dynamics and immunogenicity of a catalytically inactive CXC chemokine-degrading protease SpyCEP from Streptococcus pyogenes","volume":"18","author":"McKenna","year":"2020","journal-title":"Comput Struct Biotechnol J"},{"key":"10.1016\/j.amjms.2025.10.023_bib0102","author":"Khil"},{"key":"10.1016\/j.amjms.2025.10.023_bib0103","author":"Stevens"},{"issue":"3","key":"10.1016\/j.amjms.2025.10.023_bib0104","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1053\/j.spid.2006.07.001","article-title":"Group A Streptococcus","volume":"17","author":"Martin","year":"2006","journal-title":"Semin Pediatr Infect Dis"},{"key":"10.1016\/j.amjms.2025.10.023_bib0105","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2015.84","article-title":"Acute rheumatic fever and rheumatic heart disease","volume":"2","author":"Carapetis","year":"2016","journal-title":"Nat Rev Dis Primers"},{"issue":"6","key":"10.1016\/j.amjms.2025.10.023_bib0106","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1080\/08830185.2020.1830083","article-title":"Acute post-streptococcal glomerulonephritis: analysis of the pathogenesis","volume":"40","author":"Mosquera","year":"2021","journal-title":"Int Rev Immunol"},{"key":"10.1016\/j.amjms.2025.10.023_bib0107","article-title":"Streptococcal Toxic-Shock Syndrome: spectrum of Disease","author":"Stevens","year":"1995","journal-title":"Pathogen, New Concepts Treat"},{"issue":"7","key":"10.1016\/j.amjms.2025.10.023_bib0108","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1128\/JCM.43.7.3101-3109.2005","article-title":"Variations in emm type among group A streptococcal isolates causing invasive or noninvasive infections in a nationwide study","volume":"43","author":"Ekelund","year":"2005","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10.1016\/j.amjms.2025.10.023_bib0109","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/bmb\/ldv027","article-title":"Invasive streptococcal disease: a review for clinicians","volume":"115","author":"Parks","year":"2015","journal-title":"Br Med Bull"},{"key":"10.1016\/j.amjms.2025.10.023_bib0110","author":"Spellerberg"},{"issue":"2","key":"10.1016\/j.amjms.2025.10.023_bib0111","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0934-8840(89)80006-4","article-title":"Few-Minutes Tests for the Identification of Group A Streptococci and Enterococci with Chromogenic Substrates","volume":"272","author":"Kaufhold","year":"1989","journal-title":"Zentralblatt fur Bakteriologie"},{"issue":"11","key":"10.1016\/j.amjms.2025.10.023_bib0112","article-title":"Identification and Cluster Analysis of Streptococcus pyogenes by MALDI-TOF Mass Spectrometry","volume":"7","author":"Wang","year":"2012","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.amjms.2025.10.023_bib0113","article-title":"Rapid antigen detection test for group A streptococcus in children with pharyngitis","volume":"2016","author":"Cohen","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.amjms.2025.10.023_bib0114","author":"Gieseker"},{"issue":"23","key":"10.1016\/j.amjms.2025.10.023_bib0115","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1056\/NEJMra1600673","article-title":"Necrotizing Soft-Tissue Infections. Longo DL","volume":"377","author":"Stevens","year":"2017","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.amjms.2025.10.023_bib0116","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/cid\/ciz1000","article-title":"Streptococcus pyogenes pbp2x Mutation Confers Reduced Susceptibility to \u03b2-Lactam Antibiotics","volume":"71","author":"Vannice","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.amjms.2025.10.023_bib0117","article-title":"Genomic epidemiology of penicillin-non-susceptible Streptococcus pneumoniae","volume":"5","author":"Dew\u00e9","year":"2019","journal-title":"Microb Genom"},{"key":"10.1016\/j.amjms.2025.10.023_bib0118","volume":"94","author":"Kalra","year":"2016","journal-title":"Common Questions About Streptococcal Pharyngitis"},{"key":"10.1016\/j.amjms.2025.10.023_bib0119","first-page":"1557","article-title":"Management of Group A Beta Hemolytic Streptococcal Pharyngitis","volume":"63","author":"Hayes","year":"2001","journal-title":"Am Fam Physician"},{"issue":"2","key":"10.1016\/j.amjms.2025.10.023_bib0120","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/cid\/ciu444","article-title":"Executive summary: practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America","volume":"59","author":"Stevens","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.amjms.2025.10.023_bib0121","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S1473-3099(24)00507-3","article-title":"Adjunctive linezolid versus clindamycin for toxin inhibition in Beta;-lactam-treated patients with invasive group A streptococcal infections in 195 US hospitals from 2016 to 2021: a retrospective cohort study with target trial emulation","volume":"25","author":"Babiker","year":"2025","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"10.1016\/j.amjms.2025.10.023_bib0122","first-page":"269","article-title":"Clindamycin Affects Group A Streptococcus Virulence Factors and Improves Clinical Outcome","volume":"215","author":"Andreoni","year":"2017","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.amjms.2025.10.023_bib0123","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/cid\/ciac720","article-title":"Should Linezolid Replace Clindamycin as the Adjunctive Antimicrobial of Choice in Group A Streptococcal Necrotizing Soft Tissue Infection and Toxic Shock Syndrome? A Focused Debate","volume":"76","author":"Cort\u00e9s-Penfield","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.amjms.2025.10.023_bib0124","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/jac\/dkl173","article-title":"Human intravenous immunoglobulin for experimental streptococcal toxic shock: bacterial clearance and modulation of inflammation","volume":"58","author":"Sriskandan","year":"2006","journal-title":"J Antimicr Chemother"},{"issue":"9","key":"10.1016\/j.amjms.2025.10.023_bib0125","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1093\/cid\/ciy401","article-title":"Polyspecific Intravenous Immunoglobulin in Clindamycin-treated Patients with Streptococcal Toxic Shock Syndrome: a Systematic Review and Meta-analysis","volume":"67","author":"Parks","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.amjms.2025.10.023_bib0126","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.idc.2017.05.011","article-title":"Evaluation and Management of Necrotizing Soft Tissue Infections","volume":"31","author":"Bonne","year":"2017","journal-title":"Infect Dis Clin North Am"},{"issue":"1","key":"10.1016\/j.amjms.2025.10.023_bib0127","doi-asserted-by":"crossref","DOI":"10.1186\/s13017-018-0219-9","article-title":"2018 WSES\/SIS-E consensus conference: recommendations for the management of skin and soft-tissue infections","volume":"13","author":"Sartelli","year":"2018","journal-title":"World J Emerg Surg"},{"issue":"8","key":"10.1016\/j.amjms.2025.10.023_bib0128","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofac244","article-title":"Effectiveness and Safety of Antibiotic Prophylaxis for Persons Exposed to Cases of Invasive Group A Streptococcal Disease: a Systematic Review","volume":"9","author":"Khan","year":"2022","journal-title":"Open Forum Infect Dis"},{"issue":"2","key":"10.1016\/j.amjms.2025.10.023_bib0129","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1093\/cid\/ciae524","article-title":"Choosing Wisely: effectiveness and Safety of Antibiotic Prophylaxis in Close Contacts of Invasive Group A Streptococci Infection","volume":"80","author":"Birck","year":"2025","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.amjms.2025.10.023_bib0130","unstructured":"prevention-of-invasive-group-a-streptococcal-disease-among-house-2002."},{"issue":"7","key":"10.1016\/j.amjms.2025.10.023_bib0131","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1093\/cid\/ciz716","article-title":"Evaluating household transmission of invasive group a streptococcus disease in the United States using population-based surveillance data, 2013-2016","volume":"70","author":"Adebanjo","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.amjms.2025.10.023_bib0132","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1093\/cid\/ciy1143","article-title":"The Path to Group A Streptococcus Vaccines: world Health Organization Research and Development Technology Roadmap and Preferred Product Characteristics","volume":"69","author":"Vekemans","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.amjms.2025.10.023_bib0133","article-title":"Recent Scientific Advancements towards a Vaccine against Group A Streptococcus","volume":"12","author":"Fan","year":"2024","journal-title":"Vaccines (Basel)"},{"issue":"1","key":"10.1016\/j.amjms.2025.10.023_bib0134","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-023-00609-x","article-title":"The Streptococcus pyogenes vaccine landscape","volume":"8","author":"Walkinshaw","year":"2023","journal-title":"NPJ Vaccines"},{"issue":"46","key":"10.1016\/j.amjms.2025.10.023_bib0135","doi-asserted-by":"crossref","first-page":"8175","DOI":"10.1016\/j.vaccine.2011.09.005","article-title":"et al. New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A streptococci","volume":"29","author":"Dale","year":"2011","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.amjms.2025.10.023_bib0136","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060969","article-title":"StreptInCor: a Candidate Vaccine Epitope against S. pyogenes Infections Induces Protection in Outbred Mice","volume":"8","author":"Postol","year":"2013","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.amjms.2025.10.023_bib0137","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0198658","article-title":"Evaluation of safety and immunogenicity of a group a streptococcus vaccine candidate (mj8vax) in a randomized clinical trial","volume":"13","author":"Sekuloski","year":"2018","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.amjms.2025.10.023_bib0138","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00693-19","article-title":"An experimental group a streptococcus vaccine that reduces pharyngitis and tonsillitis in a nonhuman primate model","volume":"10","author":"Rivera-Hernandez","year":"2019","journal-title":"mBio"},{"key":"10.1016\/j.amjms.2025.10.023_bib0139","unstructured":"Group A Streptococcal Vaccine Development: current Status and Issues of Relevance to Less Developed Countries, Department of Child and Adolescent Health and Development, Department of Immunization, Vaccines and Biologicals, Group A Streptococcal Disease.; 2005."},{"issue":"6","key":"10.1016\/j.amjms.2025.10.023_bib0140","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1086\/597035","article-title":"Population-Based Study of Invasive Disease Due to \u03b2-Hemolytic Streptococci of Groups Other than A and B","volume":"48","author":"Broyles","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.amjms.2025.10.023_bib0141","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S1473-3099(20)30523-5","article-title":"Effectiveness of adjunctive clindamycin in Beta;-lactam antibiotic-treated patients with invasive haemolytic streptococcal infections in US hospitals: a retrospective multicentre cohort study","volume":"21","author":"Babiker","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"10.1016\/j.amjms.2025.10.023_bib0142","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3201\/eid2702.201945","article-title":"Increasing incidence of invasive group a streptococcus disease in first nations population, Alberta, Canada, 2003-2017","volume":"27","author":"Tyrrell","year":"2021","journal-title":"Emerg Infect Dis"},{"issue":"10","key":"10.1016\/j.amjms.2025.10.023_bib0143","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0206289","article-title":"Secular trends in incidence of invasive beta-hemolytic streptococci and efficacy of adjunctive therapy in Quebec, Canada, 1996-2016","volume":"13","author":"Couture-Cossette","year":"2018","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.amjms.2025.10.023_bib0144","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.3201\/eid2811.220029","article-title":"Invasive Infections Caused by Lancefield Groups C\/G and A Streptococcus, Western Australia, Australia, 2000\u20132018","volume":"28","author":"Wright","year":"2022","journal-title":"Emerg Infect Dis"},{"issue":"10","key":"10.1016\/j.amjms.2025.10.023_bib0145","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1007\/s10096-010-0989-9","article-title":"Epidemiology, outcome and emm types of invasive group A streptococcal infections in Finland","volume":"29","author":"Siljander","year":"2010","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"31","key":"10.1016\/j.amjms.2025.10.023_bib0146","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2023.28.31.2200807","article-title":"Invasive beta-haemolytic streptococcal infections, Finland, 2006 to 2020: increase in Lancefield group C\/G infections","volume":"28","author":"Paspaliari","year":"2023","journal-title":"Eurosurveillance"},{"issue":"42","key":"10.1016\/j.amjms.2025.10.023_bib0147","doi-asserted-by":"crossref","first-page":"15237","DOI":"10.1074\/jbc.RA119.009894","article-title":"Group A, B, C, and G Streptococcus Lancefield antigen biosynthesis is initiated by a conserved \u03b1-d-GlcNAc-\u03b2-1,4-l-rhamnosyltransferase","volume":"294","author":"Zorzoli","year":"2019","journal-title":"J Biol Chem"},{"key":"10.1016\/j.amjms.2025.10.023_bib0148","doi-asserted-by":"crossref","unstructured":"Baracco G.J. Infections Caused by Group C and G Streptococcus (Streptococcus dysgalactiae subsp. equisimilis and Others): epidemiological and Clinical Aspects. Published online April 12, 2019. doi:10.1128\/microbiolspec.GPP3.","DOI":"10.1128\/9781683670131.ch17"},{"issue":"1","key":"10.1016\/j.amjms.2025.10.023_bib0149","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1128\/CMR.1.1.102","article-title":"Streptococcus anginosus (\u201cStreptococcus milleri\u201d): the unrecognized pathogen","volume":"1","author":"Ruoff","year":"1988","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"10.1016\/j.amjms.2025.10.023_bib0150","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.GPP3-0020-2018","article-title":"Pathogenicity Factors in Group C and G Streptococci","volume":"7","author":"Turner","year":"2019","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.amjms.2025.10.023_bib0151","unstructured":"Sharma M., Khatib R., Fakih M. Clinical Characteristics of Necrotizing Fasciitis Caused by Group G Streptococcus: case Report and Review of the Literature."},{"issue":"8","key":"10.1016\/j.amjms.2025.10.023_bib0152","doi-asserted-by":"crossref","DOI":"10.1002\/ccr3.6162","article-title":"Recurrent group G Streptococcus bacteremia: a case report and literature review","volume":"10","author":"Ghazanfar","year":"2022","journal-title":"Clin Case Rep"},{"key":"10.1016\/j.amjms.2025.10.023_bib0153","article-title":"Toxic Shock Syndrome From Group C Streptococcus","volume":"20","author":"McCullough","year":"2022","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.amjms.2025.10.023_bib0154","doi-asserted-by":"crossref","first-page":"e634","DOI":"10.1002\/ams2.634","article-title":"In-hospital mortality among patients with invasive non-group A \u03b2-hemolytic Streptococcus treated with clindamycin combination therapy: a nationwide cohort study","volume":"8","author":"Hamada","year":"2021","journal-title":"Acute Med Surg"},{"issue":"5","key":"10.1016\/j.amjms.2025.10.023_bib0155","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.3201\/eid2905.221338","article-title":"Severe Streptococcus equi Subspecies zooepidemicus Outbreak from Unpasteurized Dairy Product Consumption, Italy","volume":"29","author":"Bosica","year":"2023","journal-title":"Emerg Infect Dis"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962925012613?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962925012613?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T13:55:29Z","timestamp":1769090129000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962925012613"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":155,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S0002962925012613"],"URL":"https:\/\/doi.org\/10.1016\/j.amjms.2025.10.023","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Streptococcal infections: Emerging trends, clinical spectrum and global prevention effort","name":"articletitle","label":"Article Title"},{"value":"The American Journal of the Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjms.2025.10.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}